Holmlund, Jon T.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

A Phase I trial of h-ras antisense oligonucleotide ISIS 2503 administered as a continuous intravenous infusion in patients with advanced carcinoma

C. Casey Cunningham, Jon T. Holmlund, Richard S. Geary, T. Jesse Kwoh, Andrew Dorr, Joseph F. Johnston, Brett Monia, John Nemunaitis

Journal:

Year:

2001

Language:

english

File:

PDF, 84 KB

english, 2001

2

The Mass Balance of Circum-Arctic Glaciers and Recent Climate Change

Julian A. Dowdeswell, Jon Ove Hagen, Helgi Björnsson, Andrey F. Glazovsky, William D. Harrison, Per Holmlund, Jacek Jania, Roy M. Koerner, Bernard Lefauconnier, C.Simon L. Ommanney, Robert H. Thomas

Journal:

Quaternary Research

Year:

1997

Language:

english

File:

PDF, 361 KB

english, 1997

3

Antisense Approaches for the Treatment of Cancer

Monia, Brett P., Holmlund, Jon, Dorr, F. Andrew

Journal:

Cancer Investigation

Year:

2000

Language:

english

File:

PDF, 1.46 MB

english, 2000

4

A phase I trial of aprinocarsen (ISIS 3521/LY900003), an antisense inhibitor of protein kinase C-α administered as a 24-hour weekly infusion schedule in patients with advanced cancer

Ranjana Advani, Bert L. Lum, George A. Fisher, Joanne Halsey, Richard S. Geary, Jon T. Holmlund, T. Jesse Kwoh, F. Andrew Dorr, Branimir I. Sikic

Journal:

Investigational New Drugs

Year:

2005

Language:

english

File:

PDF, 123 KB

english, 2005

5

A Phase II trial of aprinocarsen, an antisense oligonucleotide inhibitor of protein kinase C α, administered as a 21-day infusion to patients with advanced ovarian carcinoma

Ranjana Advani, Prema Peethambaram, Bert L. Lum, George A. Fisher, Lynn Hartmann, Harry J. Long, Joanne Halsey, Jon T. Holmlund, Andrew Dorr, Branimir I. Sikic

Journal:

Year:

2004

Language:

english

File:

PDF, 77 KB

english, 2004

6

Phase I Clinical/Pharmacokinetic and Pharmacodynamic Trial of the c- raf -1 Antisense Oligonucleotide ISIS 5132 (CGP 69846A)

Stevenson, James P., Yao, Kang-Shen, Gallagher, Maryann, Friedland, David, Mitchell, Edith P., Cassella, Amy, Monia, Brett, Kwoh, T. Jesse, Yu, Rosie, Holmlund, Jon, Dorr, F. Andrew, O'Dwyer, Peter J.

Journal:

Journal of Clinical Oncology

Year:

1999

Language:

english

File:

PDF, 109 KB

english, 1999

7

Double-Blind, Placebo-Controlled, Randomized Phase 2 Study of the Proapoptotic Agent AT-101 Plus Docetaxel, in Second-Line Non-small Cell Lung Cancer

Ready, Neal, Karaseva, Nina A., Orlov, Sergey V., Luft, Alexander V., Popovych, Olexandr, Holmlund, Jon T., Wood, Brian A., Leopold, Lance

Journal:

Journal of Thoracic Oncology

Year:

2011

Language:

english

File:

PDF, 195 KB

english, 2011

8

Influence of Interleukin-2 Regimens on Circulating Populations of Lymphocytes After Adoptive Transfer of Anti-CD3-Stimulated T Cells

Curti, Brendan D., Ochoa, Augusto C., Urba, Walter J., Alvord, W. Gregory, Kopp, William C., Powers, Gerry, Hawk, Connie, Creekmore, Stephen P., Gause, Barry L., Janik, John E., Holmlund, Jon T., Krem

Journal:

Journal of Immunotherapy

Year:

1996

File:

PDF, 955 KB

1996

9

The Effects of Treatment with Interleukin-1α on Platelet Recovery after High-Dose Carboplatin

Smith, John W., Longo, Dan L., Alvord, W. Gregory, Janik, John E., Sharfman, William H., Gause, Barry L., Curti, Brendan D., Creekmore, Stephen P., Holmlund, Jon T., Fenton, Robert G., Sznol, Mario, M

Journal:

Boston Medical and Surgical Journal

Year:

1993

Language:

english

File:

PDF, 1.04 MB

english, 1993

10

Abrogation of the Hematological and Biological Activities of the Interleukin-3/Granulocyte-Macrophage Colony-Stimulating Factor Fusion Protein PIXY321 by Neutralizing Anti-PIXY321 Antibodies in Cancer Patients Receiving High-Dose Carboplatin

Miller, Langdon L., Korn, Edward L., Stevens, Diane S., Janik, John E., Gause, Barry L., Kopp, William C., Holmlund, Jon T., Curti, Brendan D., Sznol, Mario, Smith, John W., Urba, Walter J., Donegan,

Journal:

Year:

1999

File:

PDF, 130 KB

1999

11

Applying Antisense Technology : Affinitak™ and Other Antisense Oligonucleotides in Clinical Development

JON T. HOLMLUND

Journal:

Annals of the New York Academy of Sciences

Year:

2003

File:

PDF, 177 KB

2003

12

A Phase II Trial of ISIS 3521 in Patients with Metastatic Colorectal Cancer

John L. Marshall, Steven G. Eisenberg, Michael D. Johnson, John Hanfelt, F. Andrew Dorr, Dorraya El-Ashry, Michael Oberst, Yair Fuxman, Jon Holmlund, Shakun Malik

Journal:

Clinical Colorectal Cancer

Year:

2004

Language:

english

File:

PDF, 443 KB

english, 2004

13

Antisense Oligonucleotides as Inhibitors of Genes That Regulate AP-1: Pharmacology and Clinical Development

DEAN, NICHOLAS M., McKAY, ROBERT A., HOLMLUND, JON

Journal:

Antisense and Nucleic Acid Drug Development

Year:

1998

Language:

english

File:

PDF, 5.33 MB

english, 1998

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски